Featured Firms
Presented by BigVoodoo
When generic firms seek FDA approval to market their products in advance of patent-term expiry, the 1984 Hatch-Waxman legislation rightly permits a branded company to immediately sue the generic for infringement. But what about the corollary prerogative to settle this kind of litigation?
September 13, 2006 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS